Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study

by Gupta, N, Goh, Y.T, Min, C.-K, Lee, J.H, Kim, K, Wong, R.S.M, Chim, C.S, Hanley, M.J, Yang, H, Venkatakrishnan, K, Hui, A.-M, Esseltine, D.-L, Chng, W.J
Published 2020